Related Experiment Video
Updated: Mar 25, 2026

07:24
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.9K
[Research Progress on Long Non-Coding RNA in Hematological Malignancies--Review].
Liu-Yan Xin1, Si-Si Zhong1,2, Ai-Fei Liu1
1Department of Hematology, The First Affiliated Hospital of Gannan Medical College, Ganzhou 341000, Jiangxi Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|February 26, 2016
Summary
Long non-coding RNAs (LncRNAs) regulate gene expression and are implicated in cancer. This review explores the specific mechanisms of LncRNAs in hematological malignancies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (LncRNAs) are RNA transcripts longer than 200 nucleotides without protein-coding function.
- While known for years, the precise roles of LncRNAs in human biological processes are still being uncovered.
- Emerging evidence highlights LncRNAs' regulatory functions in gene expression and their involvement in various diseases, including cancer.
Purpose of the Study:
- To review the current understanding of LncRNA mechanisms in the context of hematological malignancies.
- To consolidate research on the specific roles LncRNAs play in the development and progression of blood cancers.
Main Methods:
- Literature review of studies investigating LncRNA function in hematological malignancies.
- Analysis of research focusing on the molecular mechanisms by which LncRNAs influence cancer cells.
Main Results:
- LncRNAs are increasingly recognized as key players in the pathogenesis of hematological malignancies.
- Specific LncRNAs have been identified that can influence cancer cell proliferation, survival, and drug resistance.
- Understanding these mechanisms offers potential for novel diagnostic and therapeutic strategies.
Conclusions:
- LncRNAs represent a significant area of research in hematological oncology.
- Further investigation into LncRNA functions is crucial for advancing our knowledge of blood cancer biology.
- Targeting LncRNAs may offer promising avenues for future cancer therapies.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs
3.8K
3.8K
Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Types of RNA
16.2K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
16.2K
Overview of Hematopoiesis
11.2K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
11.2K
Hematopoiesis
9.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.7K

